Trial Profile
A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Octreotide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Novartis
- 27 Apr 2012 Location (USA) added as reported by ClinicalTrials.gov.
- 27 Apr 2012 Actual end date (Oct 2005 ) added as reported by ClinicalTrials.gov.
- 01 Oct 2009 New trial record